Journal Blood - May 30, 2021
" 'We have been able to unravel the root of secondary leukaemia in these children which seems to lie in the early stages of neuroblastoma treatment. We hope to further investigate this to try to identify children at higher risk, and to inform a more tailored treatment plan to reduce the risk of secondary leukaemia.' The team found that in both patients the leukaemia had mutations that were caused by neuroblastoma chemotherapy." Read article>>